Clinical trial
Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate…
NCT00002760 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00002760 |
|---|---|
| Title | Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer |
| Official title | A PHASE III TWO-ARM RANDOMIZED STUDY COMPARING ANTIANDROGEN WITHDRAWAL ALONE VERSUS ANTIANDROGEN WITHDRAWAL COMBINED WITH KETOCONAZOLE AND HYDROCORTISON IN PATIENTS WITH ADVANCED PROSTAGE CANCER |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Other |
| Interventions | ketoconazole, therapeutic hydrocortisone, Withdrawal of antiandrogen therapy |
| Enrollment | 260 |
| Start date | Aug 1, 1996 |
| Primary completion | Mar 1, 2004 |
| Completion | Apr 1, 2009 |
| First posted | Jul 19, 2004 |
| Last update posted | Jun 28, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: